Published in Int J Cancer on December 15, 1987
Perinatal and multigenerational effect of carcinogens: possible contribution to determination of cancer susceptibility. Environ Health Perspect (1992) 0.98
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res (1994) 11.29
Clinical implications of the p53 tumor-suppressor gene. N Engl J Med (1993) 7.29
Active and passive smoking and pathological indicators of lung cancer risk in an autopsy study. JAMA (1992) 6.56
p53 and human cancer: the first ten thousand mutations. Adv Cancer Res (2000) 4.71
IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res (1998) 3.74
Results from a historical survey of the survival of cancer patients given Di Bella multitherapy. Cancer (1999) 2.68
A new Salmonella tester strain (TA102) with A X T base pairs at the site of mutation detects oxidative mutagens. Proc Natl Acad Sci U S A (1982) 2.67
Dengue 3 virus transmission in Africa. Am J Trop Med Hyg (1986) 2.17
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects. Nucleic Acids Res (1997) 2.17
Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer (1996) 1.82
Evaluation of the carcinogenicity of chemicals: a review of the Monograph Program of the International Agency for Research on Cancer (1971 to 1977). Cancer Res (1978) 1.73
Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res (2000) 1.73
Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium. Nature (1975) 1.66
Short-term tests for carcinogens and mutagens. Mutat Res (1979) 1.62
Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Oncogene (2001) 1.57
Geographic variation of p53 mutational profile in nonmalignant human liver. Science (1994) 1.51
UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. Proc Natl Acad Sci U S A (1994) 1.50
Determining carcinogenicity. Science (1993) 1.39
Clinical implications of the p53 gene. Annu Rev Med (1996) 1.38
Are evaluations of carcinogenicity by various committees worth comparing? Med Lav (1994) 1.37
Production of epithelial and mesenchymal tumours with rat liver cells transformed in vitro. Int J Cancer (1975) 1.33
Modulation of leg muscle activity and gait kinematics by walking speed and bodyweight unloading. Gait Posture (2005) 1.24
The predictive value of rodent carcinogenicity tests in the evaluation of human risks. Annu Rev Pharmacol Toxicol (1979) 1.24
Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran. Cancer Res (2001) 1.17
Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J Natl Cancer Inst (1995) 1.15
The effect of long-term exposure to DDT on CF-1 MICE. Int J Cancer (1972) 1.14
Inactivation of the p53 protein in cell lines derived from human esophageal cancers. Int J Cancer (1997) 1.13
Common tumour p53 mutations in immortalized cells from Hupki mice heterozygous at codon 72. Oncogene (2007) 1.13
Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophageal cancer in Iran. Mutat Res (1985) 1.11
Malignant transformation in vitro of rat liver cells by dimethylnitrosamine and N-methyl-N'-nitro-N-nitrosoguanidine. Br J Cancer (1973) 1.11
Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol (1976) 1.11
Gap junctional intercellular communication and carcinogenesis. Carcinogenesis (1990) 1.11
Alphafetoprotein levels of liver cancer patients and controls in a European population. Cancer (1980) 1.09
Gene expression in human peripheral blood mononuclear cells upon acute ischemic stroke. J Neurol (2008) 1.09
Tumors in CF-1 mice exposed for six consecutive generations to DDT. J Natl Cancer Inst (1973) 1.08
The predictive value of mouse liver tumour induction in carcinogenicity testing--a literature survey. Int J Cancer (1973) 1.08
Presence of an EcoRI RFLP of the c-mos locus in normal and tumor tissue of esophageal cancer patients. Nucleic Acids Res (1986) 1.08
Diethylstilboestrol: I, Pharmacology, Toxicology and carcinogenicity in humans. Eur J Cancer (1992) 1.07
The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway. Oncogene (2007) 1.03
Carcinogenic activity of hexacholorobenzene in hamsters. Nature (1977) 1.02
Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol Carcinog (1993) 1.01
Lung tumors in rats treated with N-nitrosoheptamethyleneimine and N-nitrosooctamethyleneimine. Proc Soc Exp Biol Med (1969) 1.01
Diethylstilboestrol: II, pharmacology, toxicology and carcinogenicity in experimental animals. Eur J Cancer (1992) 1.01
Inequalities in cancer risks. Semin Oncol (2001) 1.00
Poverty and cancer. Cancer Epidemiol Biomarkers Prev (1993) 0.99
Poly(ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice. Oncogene (2006) 0.99
Perinatal and multigenerational effect of carcinogens: possible contribution to determination of cancer susceptibility. Environ Health Perspect (1992) 0.98
Storage levels of DDT metabolites in mouse tissues following long term exposure to technical DDT. Tumori (1972) 0.97
Chemicals and industrial processes associated with cancer in humans. IARC Monographs, Volumes 1 to 20. IARC Monogr Eval Carcinog Risk Chem Hum Suppl (1979) 0.97
Long-term hazards of polychlorinated dibenzodioxins and polychlorinated dibenzofurans. Environ Health Perspect (1980) 0.96
Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test. Diagn Microbiol Infect Dis (1999) 0.96
Carcinogenicity of chloroethylene oxide, an ultimate reactive metabolite of vinyl chloride, and bis(chloromethyl)ether after subcutaneous administration and in initiation-promotion experiments in mice. Cancer Res (1980) 0.95
Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine (2000) 0.94
An evaluation of the genetic toxicity of epichlorohydrin. A report of an expert group of the International Commission for Protection against Environmental Mutagens and Carcinogens. Mutat Res (1981) 0.94
Selective lack of intercellular communication between transformed and nontransformed cells as a common property of chemical and oncogene transformation of BALB/c 3T3 cells. Cancer Res (1987) 0.93
Goitre and wasting induced in hamsters by hexachlorobenzene. Arch Toxicol (1987) 0.93
Ethical aspects of prevention. Scand J Work Environ Health (1995) 0.93
The effects of multiple and single administration of dimethylnitrosamine to hamsters. Tumori (1968) 0.92
Increased cancer incidence in the progeny of male rats exposed to ethylnitrosourea before mating. Int J Cancer (1981) 0.92
Hepatocarcinogenicity of hexachlorobenzene in rats and the sex difference in hepatic iron status and development of porphyria. Carcinogenesis (1985) 0.91
UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin. Cancer Res (2001) 0.91
Analysis of human prostate cancers and cell lines for mutations in the TP53 and KLF6 tumour suppressor genes. Br J Cancer (2003) 0.91
A difference between two strains of rats in their liver non-haem iron content and in their response to the porphyrogenic effect of hexachlorobenzene. Chem Biol Interact (1979) 0.91
The IARC program on the evaluation of the carcinogenic risk of chemicals to man. Ann N Y Acad Sci (1976) 0.91
Protection against mercuric chloride by nephrotoxic agents which do not induce thionein. Toxicol Appl Pharmacol (1980) 0.90
An evaluation of chemicals and industrial processes associated with cancer in humans based on human and animal data: IARC Monographs Volumes 1 to 20. Cancer Res (1980) 0.90
Results of the second international study on the W.H.O. alpha-foetoprotein standard. J Biol Stand (1978) 0.90
Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells. Cancer Res (1988) 0.90
Screening for putative radon-specific p53 mutation hotspot in German uranium miners. Lancet (1995) 0.89
Tumour promoter-mediated reversible inhibition of cell-cell communication (electrical coupling). Relationship with phorbol ester binding and de novo macromolecule synthesis. Exp Cell Res (1983) 0.89
Prevention of air embolism during open-heart surgery: a study of the role of trapped air in the left ventricle. Surgery (1970) 0.89
Subcutaneous soft tissue tumours at the site of implanted microchips in mice. Exp Toxicol Pathol (1997) 0.89
Report of the policy conference on pacemaker reuse sponsored by the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol (1985) 0.89
Alpha-Fetoprotein levels in normal males from seven ethnic groups with different hepatocellular carcinoma risks. Ann N Y Acad Sci (1975) 0.89
Ki-ras gene mutations and absence of p53 gene mutations in spontaneous and urethane-induced early lung lesions in CBA/J mice. Mol Carcinog (1998) 0.88
Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences. Mutat Res (2006) 0.88
Effects of ethylnitrosourea administration during pregnancy on three subsequent generations of BDVI Rats. Int J Cancer (1977) 0.88
Liver-cell tumours in rats fed hexachlorobenzene. Cancer Lett (1980) 0.88
Effects of long-term intake of DDT on rats. Tumori (1982) 0.87
Gap junctional intercellular communication and cell proliferation during rat liver carcinogenesis. Environ Health Perspect (1993) 0.87
Effect of long-term exposure to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene, to 1,1-dichloro-2,2-bis(p-chlorophenyl)ethane, and to the two chemicals combined on CF-1 mice. J Natl Cancer Inst (1974) 0.87
The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats. Cancer Lett (1983) 0.87
The contribution of epidemiological and experimental data to the control of environmental carcinogens. Cancer Lett (1985) 0.87
Mean alpha-fetoprotein values of 1,333 males over 15 years by age groups. Digestion (1977) 0.87
Low frequency of p16/CDKN2 gene mutations in esophageal carcinomas. Int J Cancer (1996) 0.86
Screening for p53 gene mutations in archived tumors of workers occupationally exposed to carcinogens: examples from analysis of bladder tumors. J Occup Environ Med (1995) 0.86
Carcinogenesis of hexachlorobenzene in mice. Int J Cancer (1979) 0.86
A carcinogenicity study of pesticide dieldrin in hamsters. Cancer Lett (1979) 0.86
Mouse models with modified p53 sequences to study cancer and ageing. Cell Death Differ (2003) 0.86
Carcinogenesis bioassays: study duration and biological relevance. Food Chem Toxicol (2001) 0.86
Massive arterial air embolism due to rupture of pulsatile assist device: successful treatment in the hyperbaric chamber. Ann Thorac Surg (1981) 0.86
A randomized study comparing clinical efficacy and safety of thienamycin formamidine (MK0787)/renal dipeptidase inhibitor (MK0791) and cefazolin. J Antimicrob Chemother (1983) 0.86
Testicular mesotheliomas in rats exposed to N-2-fluorenylacetamide (FAA). Tumori (1983) 0.85